A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma
Clinical trial NCT03970616 · TERMINATED
Trial details
- NCT number
- NCT03970616
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2023-04-04
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.